Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
Linda Petrone, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.
International Journal of Infectious Diseases (2022) Vol. 121, pp. 24-30
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
Alessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 841-849
Open Access | Times Cited: 29
Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
Alessandra Aiello, Saeid Najafi Fard, Delia Goletti
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Ricardo da Silva Antunes, Daniela Weiskopf, John Sidney, et al.
Current Protocols (2023) Vol. 3, Iss. 11
Open Access | Times Cited: 15
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 22
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis
Pedro Martínez‐Fleta, Esther F. Vicente‐Rabaneda, Ana Triguero‐Martínez, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
Serena Vita, Alessandra D’Abramo, Andrea Coppola, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
Tonino Alonzi, Alessandra Aiello, Michela Sali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117153-117153
Open Access | Times Cited: 3
Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
Alessandra Aiello, Adriano Grossi, Silvia Meschi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
COVID-19 and multiple sclerosis: challenges and lessons for patient care
Luca Prosperini, Georgina Arrambide, Elisabeth Gulowsen Celius, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 100979-100979
Open Access | Times Cited: 2
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant
A. Del Mastro, Stefania Picascia, Luciana D’Apice, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1132-1132
Open Access | Times Cited: 5
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
Saeid Najafi Fard, Elisa Petruccioli, Chiara Farroni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
COVID-19 and rheumatic diseases: A mini-review
Livia Roseti, Brunella Grigolo
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis
David Stahl, Carola tho Pesch, Carolin Brück, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002632-e002632
Open Access | Times Cited: 8
Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
Gianfranco Alicandro, B.S. Orena, Chiara Rosazza, et al.
Vaccine (2023) Vol. 41, Iss. 28, pp. 4114-4120
Open Access | Times Cited: 4
Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis
Jenna M. Benoit, Jessica A. Breznik, Jann C. Ang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants
Rashed Noor
Viruses (2022) Vol. 14, Iss. 11, pp. 2541-2541
Open Access | Times Cited: 7
Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
Shuyi Wang, Jin Li, Shuang Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine
Holly Dudley, Megan L. O’Mara, Ann Auma, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6112-6119
Open Access | Times Cited: 3
Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
Yapei Huang, Juliana Shin, Alexander M. Xu, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105209-105209
Open Access | Times Cited: 4
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls
Tali Eviatar, A Pappo, Tal Freund, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 2, pp. 167-172
Closed Access
Monitoring of adaptive immune responses in healthcare workers who received a Coronavirus disease 2019 vaccine booster dose
Chompunuch Klinmalai, Supanart Srisala, Thiantip Sahakijpicharn, et al.
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Page 1 - Next Page

Scroll to top